Barclays PLC Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $1.31 Million - $1.98 Million	20,200 Added 3366.67%	20,800 $1.78 Million
Q4 2019 Feb 10, 2020	SELL	$40.86 - $57.65 $792,684 - $1.12 Million	-19,400 Reduced 97.0%	600 $33,000
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $5.96 Million - $10 Million	-149,800 Reduced 88.22%	20,000 $876,000
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $3.82 Million - $5.87 Million	169,800 New	169,800 $4.37 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.